Entering text into the input field will update the search result below

Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2021 Results - Earnings Call Transcript

Mar. 01, 2022 9:52 PM ETJazz Pharmaceuticals plc (JAZZ)
SA Transcripts profile picture
SA Transcripts
140.57K Followers

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET

Company Participants

Andrea Flynn - VP & Head, IR

Bruce Cozadd - Co-Founder, Chairman & CEO

Daniel Swisher - President

Robert Iannone - EVP, Research & Development & Chief Medical Officer

Renée Galá - EVP & CFO

Kim Sablich - EVP & GM, North America

Conference Call Participants

Kenneth Cacciatore - Cowen and Company

Jessica Fye - JPMorgan

Akash Tewari - Jefferies

Marc Goodman - SVB Leerink

Jason Gerberry - BofA Securities

Ami Fadia - Needham & Company

Aaron Gal - Sanford C. Bernstein

Balaji Prasad - Barclays

Annabel Samimy - Stifel

Gary Nachman - BMO Capital Markets

David Amsellem - Piper Sandler

Navann Ty - Citigroup Inc.

Gregory Fraser - Truist Securities

Operator

Good day, and welcome to the Fourth Quarter 2021 Jazz Pharmaceuticals Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. As a reminder, this call may be recorded.

I would now like to turn the call over to Andrea Flynn, Head of Investor Relations. You may begin.

Andrea Flynn

Thank you, and good afternoon, everyone. Today, Jazz Pharmaceuticals reported its fourth quarter and full year 2021 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website. Investors may also refer to the press release we issued earlier today, which is also posted to our website.

On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renée Galá, Executive Vice President and Chief Financial Officer; Dan Swisher, President; and Rob Iannone, Executive Vice President, Global Head of R&D. Kim Sablich, Executive Vice President and General Manager, North America, will join the team for Q&A.

On Slide 2, I'll

Recommended For You

Comments

To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.